Skip to main content

Table 2 Potassium values

From: Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease – a post-hoc analysis of the PARAT trial

 

Mean ± SD (mmol/l)

> 5 to ≤5.5 mmol/l (%)

> 5.5 mmol/l (%)*

 

Certo

Plac

p-value**

Certo

Plac

Certo

Plac

Baseline

4.2 ± 0.4

4.2 ± 0.4

p = n.s.

3.5

0

0

0

Discharge

4.2 ± 0.4

4.2 ± 0.4

p = n.s.

3.9

4

0

0

2 weeks

4.5 ± 0.4

4.5 ± 0.4

p = n.s.

8.3

6

0

2

4-6 weeks

4.4 ± 0.4

4.4 ± 0.4

p = n.s.

8.9

4.3

0

2.2

3 months

4.4 ± 0.3

4.5 ± 0.3

p = n.s.

4.8

4.4

0

0

6 months

4.3 ± 0.3

4.3 ± 0.4

p = n.s.

4.9

2.4

0

0

  1. Legend: *there were no patients with a serum potassium > 6.0 mmol/l; **the statistical evaluation was performed using paired, two sided t-test for each of the treatment groups to compare baseline and follow-up values.
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us